A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression
Condition:   Depressive Disorder Interventions:   Drug: sulforaphane;   Other: placedo;   Drug: Escitalopram Sponsor:   Central South University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials

Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
Conditions:   Anxious Depression;   Depression Interventions:   Drug: Escitalopram;   Drug: Duloxetine Sponsor:   University of Cincinnati Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials

Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
Conditions:   Anxiety;   Depressive Symptoms Interventions:   Drug: Duloxetine;   Drug: Escitalopram Sponsor:   University of Cincinnati Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials

A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression
Condition:   Depressive Disorder Interventions:   Drug: sulforaphane;   Other: placedo;   Drug: Escitalopram Sponsor:   Central South University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials

Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
Conditions:   Anxious Depression;   Depression Interventions:   Drug: Escitalopram;   Drug: Duloxetine Sponsor:   University of Cincinnati Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials